$PFE Headlines Mega caps with mega recommendat
Post# of 102469
Posted On: 08/06/2014 11:06:36 AM
$PFE Headlines
Mega caps with mega recommendations 7:54 a.m. Today - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
AbbVie, Shire set to announce merger as early as Friday: report 4:54 a.m. July 18, 2014 - blogs.marketwatch.com
Slim chances seen for tax 'inversion' clampdown, analysts say 10:58 a.m. July 16, 2014 - blogs.marketwatch.com
U.S. 'inversion' takeovers strike fear in Europe 4:03 a.m. July 15, 2014 - MarketWatch.com
U.K. ready to toughen up takeover rules 7:36 a.m. July 14, 2014 - Peter Evans
GoPro versus Twitter versus Facebook 2:01 p.m. July 3, 2014 - Mark Hulbert
Update: Pfizer Can Not Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Update: Pfizer Cannot Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Top Analyst Upgrades and Downgrades: Groupon, Micron, RingCentral, Target, Tesla, Monster, Pfizer and More 8:06 a.m. Today - 247WallSt.com
Jefferies Picks Top Franchise Stocks to Buy 7:32 a.m. Today - 247WallSt.com
Zoetis Profit Up on Strong U.S. Sales 6:27 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Drugmaker AstraZeneca Returns To Growth 4:22 p.m. Aug. 5, 2014 - Investors Business Daily
How Tax Inversions Became the Hottest Trend in M&A 3:34 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog 3:00 p.m. Aug. 5, 2014 - Zacks.com
Widely Held Guru Stocks Near 52-Week Lows 9:51 a.m. Aug. 5, 2014 - GuruFocus.com
AstraZeneca Has 30% Upside As A Takeover Candidate 8:10 a.m. Aug. 5, 2014 - Seeking Alpha
Johnson & Johnson Can Only Get Better When It Gets Cheaper 6:00 a.m. Aug. 5, 2014 - TheStreet.com
Spin-Offs 101 And Value Creation 3:40 p.m. Aug. 4, 2014 - TheStreet.com
Dow 30 Stock Roundup: AmEx, XOM, PFE Beat on Earnings, CAT to Buy Back Shares - Analyst Blog 1:17 p.m. Aug. 4, 2014 - Zacks.com
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
American Express, Boeing, 5 Others Are Dragging Down the Dow 30 12:14 p.m. Aug. 4, 2014 - TheStreet.com
Walgreen Names New CFO Ahead of Possible Inversion 11:29 a.m. Aug. 4, 2014 - Investors Business Daily
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS 10:12 a.m. Aug. 4, 2014 - GuruFocus.com
3 Stocks Reiterated As A Buy: PFE, REGN, PEP 9:59 a.m. Aug. 4, 2014 - TheStreet.com
Ken Fisher's Top Stock Picks 7:30 a.m. Aug. 4, 2014 - Seeking Alpha
Retirement Strategy: The ETF Only Portfolio Vs. Buy The Dips Portfolio: Update For July 8:33 a.m. Aug. 3, 2014 - Seeking Alpha
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer 9:10 a.m. July 31, 2014 - PR Newswire - PRF
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 10:33 a.m. July 30, 2014 - PR Newswire - PRF
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer 8:02 a.m. July 30, 2014 - BusinessWire - BZX
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines 8:02 a.m. July 30, 2014 - BusinessWire - BZX
BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS 7:06 a.m. July 29, 2014 - GlobeNewswire
European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:03 a.m. July 29, 2014 - BusinessWire - BZX
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Premier Biomedical Gears Up for Two Important Clinical Trials 8:04 a.m. July 25, 2014 - ACCESSWIRE
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014 1:33 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Insomnia Global Clinical Trials Review, H2, 2014 1:14 p.m. July 23, 2014 - PR Newswire - PRF
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion 8:06 a.m. July 17, 2014 - BusinessWire - BZX
Pfizer to Acquire InnoPharma, Inc. 9:26 a.m. July 16, 2014 - BusinessWire - BZX
Mega caps with mega recommendations 7:54 a.m. Today - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
AbbVie, Shire set to announce merger as early as Friday: report 4:54 a.m. July 18, 2014 - blogs.marketwatch.com
Slim chances seen for tax 'inversion' clampdown, analysts say 10:58 a.m. July 16, 2014 - blogs.marketwatch.com
U.S. 'inversion' takeovers strike fear in Europe 4:03 a.m. July 15, 2014 - MarketWatch.com
U.K. ready to toughen up takeover rules 7:36 a.m. July 14, 2014 - Peter Evans
GoPro versus Twitter versus Facebook 2:01 p.m. July 3, 2014 - Mark Hulbert
Update: Pfizer Can Not Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Update: Pfizer Cannot Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Top Analyst Upgrades and Downgrades: Groupon, Micron, RingCentral, Target, Tesla, Monster, Pfizer and More 8:06 a.m. Today - 247WallSt.com
Jefferies Picks Top Franchise Stocks to Buy 7:32 a.m. Today - 247WallSt.com
Zoetis Profit Up on Strong U.S. Sales 6:27 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Drugmaker AstraZeneca Returns To Growth 4:22 p.m. Aug. 5, 2014 - Investors Business Daily
How Tax Inversions Became the Hottest Trend in M&A 3:34 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog 3:00 p.m. Aug. 5, 2014 - Zacks.com
Widely Held Guru Stocks Near 52-Week Lows 9:51 a.m. Aug. 5, 2014 - GuruFocus.com
AstraZeneca Has 30% Upside As A Takeover Candidate 8:10 a.m. Aug. 5, 2014 - Seeking Alpha
Johnson & Johnson Can Only Get Better When It Gets Cheaper 6:00 a.m. Aug. 5, 2014 - TheStreet.com
Spin-Offs 101 And Value Creation 3:40 p.m. Aug. 4, 2014 - TheStreet.com
Dow 30 Stock Roundup: AmEx, XOM, PFE Beat on Earnings, CAT to Buy Back Shares - Analyst Blog 1:17 p.m. Aug. 4, 2014 - Zacks.com
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
American Express, Boeing, 5 Others Are Dragging Down the Dow 30 12:14 p.m. Aug. 4, 2014 - TheStreet.com
Walgreen Names New CFO Ahead of Possible Inversion 11:29 a.m. Aug. 4, 2014 - Investors Business Daily
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS 10:12 a.m. Aug. 4, 2014 - GuruFocus.com
3 Stocks Reiterated As A Buy: PFE, REGN, PEP 9:59 a.m. Aug. 4, 2014 - TheStreet.com
Ken Fisher's Top Stock Picks 7:30 a.m. Aug. 4, 2014 - Seeking Alpha
Retirement Strategy: The ETF Only Portfolio Vs. Buy The Dips Portfolio: Update For July 8:33 a.m. Aug. 3, 2014 - Seeking Alpha
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer 9:10 a.m. July 31, 2014 - PR Newswire - PRF
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 10:33 a.m. July 30, 2014 - PR Newswire - PRF
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer 8:02 a.m. July 30, 2014 - BusinessWire - BZX
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines 8:02 a.m. July 30, 2014 - BusinessWire - BZX
BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS 7:06 a.m. July 29, 2014 - GlobeNewswire
European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:03 a.m. July 29, 2014 - BusinessWire - BZX
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Premier Biomedical Gears Up for Two Important Clinical Trials 8:04 a.m. July 25, 2014 - ACCESSWIRE
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014 1:33 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Insomnia Global Clinical Trials Review, H2, 2014 1:14 p.m. July 23, 2014 - PR Newswire - PRF
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion 8:06 a.m. July 17, 2014 - BusinessWire - BZX
Pfizer to Acquire InnoPharma, Inc. 9:26 a.m. July 16, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼